90 filings
25-NSE
CDAKQ
Codiak BioSciences, Inc.
2 May 23
Exchange delisting
1:35pm
NT 10-K
CDAKQ
Codiak BioSciences, Inc.
28 Mar 23
Notice of late annual filing
7:34pm
8-K
CDAKQ
Codiak BioSciences, Inc.
28 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:28pm
8-K
CDAKQ
Codiak BioSciences, Inc.
27 Mar 23
Bankruptcy or Receivership
9:59am
10-Q
2022 Q3
CDAKQ
Codiak BioSciences, Inc.
Quarterly report
3 Nov 22
4:14pm
8-K
3yflpe8262 t3m
3 Nov 22
Codiak BioSciences Reports Third Quarter 2022 Financial Results and Third Quarter 2022 and Recent Highlights
4:11pm
8-K
h7e 8znly6txm8k
13 Sep 22
Codiak Announces Proposed Public Offering of Common Stock and Warrants
8:38pm
424B5
gsv2x pk2nun
13 Sep 22
Prospectus supplement for primary offering
8:35pm
424B5
t6aa4hoqvgq
12 Sep 22
Prospectus supplement for primary offering
4:16pm
8-K
ocvvh
30 Aug 22
Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring
9:19am
8-K
1dwlkmewglpr1cf
4 Aug 22
Codiak BioSciences Reports Second Quarter 2022 Financial Results and Second Quarter 2022 and Recent Highlights
4:07pm
8-K
e8f9ug69f45a8f
30 Jun 22
Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials
6:36am
8-K
x0ydwhkd29noua4luhf5
29 Jun 22
Other Events
8:08am
8-K
jjbcxn
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
8g23tk8 9pmkqc3ox41
5 May 22
Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational Progress
12:00am
DEFA14A
q9a6a9se2yk22qy
29 Apr 22
Additional proxy soliciting materials
12:00am
S-8
li8ilg 7uh7fczo35
10 Mar 22
Registration of securities for employees
4:46pm